MIP-1095 (RPS-001) TFA is a potent inhibitor of PSMA with good biodistribution and efficient targeting of tumor lesions. In applications, MIP-1095 TFA will be isotopically labeled ( 131 I labeled) as an imaging probe to indicate tumor progression. And 131 I-MIP-1095 showed higher renal uptake in mice.